Pharmarise Holdings Corporation (TYO:2796)
Japan
· Delayed Price · Currency is JPY 510.00
0.00 (0.00%)
Mar 9, 2026, 3:30 PM JST
Pharmarise Holdings Revenue
Pharmarise Holdings had revenue of 16.85B JPY in the quarter ending November 30, 2025, with 10.03% growth. This brings the company's revenue in the last twelve months to 66.57B, up 14.65% year-over-year. In the fiscal year ending May 31, 2025, Pharmarise Holdings had annual revenue of 63.51B with 16.60% growth.
Revenue (ttm)
66.57B
Revenue Growth
+14.65%
P/S Ratio
0.09
Revenue / Employee
32.65M
Employees
2,039
Market Cap
5.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 63.51B | 9.04B | 16.60% |
| May 31, 2024 | 54.47B | 2.44B | 4.68% |
| May 31, 2023 | 52.03B | 422.00M | 0.82% |
| May 31, 2022 | 51.61B | -716.00M | -1.37% |
| May 31, 2021 | 52.32B | 1.29B | 2.54% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tsubota Laboratory | 710.43M |
| Satudora Holdings | 100.84B |
| Medical System Network | 129.18B |
| Ohki Healthcare Holdings | 359.41B |
| Astena Holdings | 62.74B |
| YAKUODO HOLDINGS | 161.03B |
| Shinnihonseiyaku | 41.31B |
| Heartseed | 3.03B |